Business
Press Release Jun 09 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 09, 2023, titled "Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in Non-Alcoholic Fatty Liver Disease (NAFLD) patients with comorbidities".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 09, 2023, titled \"Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in Non-Alcoholic Fatty Liver Disease (NAFLD) patients with comorbidities\". View Attachment","length":430,"tagName":"div"}]